zilongjin

01/01/2023 - "To objectively evaluate the efficacy of the Zilongjin tablets in non-small cell lung cancer (NSCLC) and to explore its potential mechanism of action against NSCLC and COVID-19 based on network pharmacology. "
01/01/2023 - "A meta-analysis of the Zilongjin tablets for non-small cell lung cancer and its network pharmacology of action against NSCLC and COVID-19."

01/01/2023 - "At the same time, the Zilongjin tablets may modulate the inflammatory response to alleviate NSCLC and COVID-19."
01/01/2023 - "To objectively evaluate the efficacy of the Zilongjin tablets in non-small cell lung cancer (NSCLC) and to explore its potential mechanism of action against NSCLC and COVID-19 based on network pharmacology. "
01/01/2023 - "A meta-analysis of the Zilongjin tablets for non-small cell lung cancer and its network pharmacology of action against NSCLC and COVID-19."

06/01/2010 - "To explore the mechanism of action of Zilongjin (ZLJ) in antagonizing multi-drug resistance (MDR) of tumor cells. "
06/01/2010 - "[Mechanism of Chinese herbal compound Zilongjin for antagonizing multi-drug resistance of tumor cells]."
05/01/2010 - "However, the mechanisms of anti-cancer activity of Zilongjin are still largely unkonwn. "
05/01/2010 - "Zilongjin, a complementary Chinese herbal medicine, has been used to alleviate the adverse effects of chemotherapeutic drugs in cancer therapy. "
04/01/2001 - "[Study on common character of regulative molecular mechanism of Chinese drug bailong and hexamethylen bisacetamide in human cancer cell cycle and their oncogene and tumor suppressor gene expression]."

12/01/2010 - "[Experimental study on suppressive effect of zilongjin on growth of human breast cancer cell line MCF-7 in vitro and in vivo]."
01/01/2010 - "To study the effect of Zilongjin (ZLJ, a composite Chinese drug) on proliferation and apoptosis of human breast carcinoma cell line MCF-7. "
12/01/2010 - "To investigate the suppressive effect and mechanism of action of Zilongjin (ZLJ, a composite Chinese drug) on the growth of human breast carcinoma cell line MCF-7 in vivo and in vivo. "
01/01/2010 - "[Effects of zilongjin on proliferation and apoptosis of human breast cancer cell line MCF-7]."
05/01/2010 - "(i) These results provide a new insight into the molecular mechanisms of Zilongjin on therapy for breast cancer. "

07/01/1999 - "To observe the reversive effect of Composite Bailong recipe (BR), a preparation of Chinese herbal medicine, on proliferation phenotype of human gastric carcinoma BGC82-3 cell line. "
07/01/1999 - "[Effect of bailong recipe on proliferation phenotype of human gastric carcinoma BGC82-3 cell line]."
10/01/1999 - "[Effect of compound Chinese drug bailong on the expression of tumor suppressor genes and relationship with prekallikrein activator signal pathway in human gastric carcinoma BGC82-3 cell line]."
10/01/2011 - "Genome wide expression analysis of the effect of the Chinese patent medicine Zilongjin tablet on four human lung carcinoma cell lines."